Pinnacle Digest: Looking For Shareholder Opinions On Ingen Technologies' Latest News
Nov 02, 2009 (M2 PRESSWIRE via COMTEX) -- www.PinnacleDigest.com is a performance-driven online financial magazine and social network with a proven track record. After Friday's news from Ingen Technologies, Inc. (Pink Sheets:IGNT) announcing that the company has hired Anton & Chia, LLP as the new auditing firm after dismissing Child, Van Wagoner and Bradshaw on Wednesday of this week, our team is inviting all shareholders to their exclusive investor controlled forum. Our staff and members have requested that all Ingen shareholders join our community and share their thoughts on the company, its development and future outlook. One of the most important aspects when we research for new investments is to understand the sentiment of the current shareholders; that is why we have released this announcement - we want to know your opinion. Join The Ingen Investor Discussion Here: http://www.pinnacledigest.com/company/ignt
Join PinnacleDigest.com to
Find out if Ingen makes it as a Pinnacle Featured Company,
Chat with other shareholders invested in Ingen,
Explain to our investor community what differentiates this company,
Connect with investors and professionals in the equity markets,
Meet the thousands of investors who have already become members of the Pinnacle community.
PinnacleDigest.com is an investment club comprised of over 15,000 members. We use all of our member's insight when selecting our next investment opportunity. Your membership is free - join today.
PinnacleDigest.com has no vested interest in the company mentioned herein. The company mentioned in this release has not compensated PinnacleDigest.com in any form to disseminate this release.
This source of information is from an unbiased perspective. If you wish to become a member of www.pinnacledigest.com you will be gaining access to articles similar to this one and many other useful services we know you will find valuable. Keeping you educated and up-to-date with the market is one of our main purposes. Our approach in achieving this goal and our ability to consistently deliver high quality investment material is what defines our business model.
This news release shall not constitute an offer to sell or the solicitation of any offer to buy securities in any jurisdiction.
All material herein was prepared by Pinnacledigest.com (Pinnacle Digest) based upon information believed to be reliable. The information contained herein is not guaranteed by Pinnacledigest.com to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Pinnacledigest.com is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. Pinnacledigest.com may receive compensation in cash or shares from independent third parties or from the companies mentioned.
Pinnacledigest.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Pinnacledigest.com undertakes no obligation to update such statements.
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to email@example.com.
(C)1994-2009 M2 COMMUNICATIONS -0-
Posts: 141 | From: new jersey | Registered: Oct 2009
| IP: Logged |
Ingen Technologies is an FDA registered medical device manufacturer of Oxyview and Oxyview Nasal Cannula products designed for the growing respiratory patient market in the USA and abroad. The Oxyview and Oxyview Nasal Cannula provide the physician, respiratory therapist and patient the means to accurately measure the oxygen flow rate being delivered from any source. Our special patented "gravity-independent" technology is innovative and cutting-edge medical technology that provides assurance and safety to millions of home oxygen patients and hospitalized patients that are required to use supplementary oxygen. Patients using portable oxygen concentrators, home oxygen concentrators, liquid oxygen and oxygen gas will improve their oxygen therapy and benefit with the use of the Oxyview and Oxyview Nasal Cannula. Ingen Technologies is a supporter of the COPD Foundation, National Home Oxygen Patient Association, American Lung Association, American Academy of Respiratory Care, American College of Chest Physicians and various hospital and government based organizations that support oxygen therapy and pulmonary diseases worldwide.
Ingen Technologies, Inc. introduces Oxyview, the World's First Patient In-Line Oxygen Flow-Meter, and Oxyview Nasal Cannula, the World's First Cannula with a built-in oxygen flow meter. This is another innovative respiratory product manufactured in the USA by Ingen Technologies; providing more confidence and assurance to patients who require home oxygen therapy or supplemental oxygen. Oxyview is reusable and the Oxyview Nasal Cannula is a disposable soft-tip, latex free cannula that requires no batteries, and pneumatically works all the time in any position with all liquid or gas O2 systems. The flow of oxygen can now be detected nearest the patient where oxygen flow matters the most. Oxygen suppliers, respiratory equipment manufacturers, medical supply stores and patients will appreciate benefits and cost savings when using Oxyview or the Oxyview Nasal Cannula.
Posts: 3 | Registered: Jan 2010
| IP: Logged |